Powerful weight-loss drugs are expanding use of U.S. health care as patients starting prescriptions are diagnosed with obesity-related conditions or take the drugs to become...
- Powerful weight-loss drugs are expanding use of U.S. health care as patients starting prescriptions are diagnosed with obesity-related conditions or take the drugs to become eligible for other services, health records and discussions with doctors show.
Novo Nordisk's Wegovy and Ozempic and Eli Lilly's Zepbound and Mounjaro have been shown to lead to average weight loss of at least 15%. The most obese patients were twice as likely as people who were less overweight to receive a type 2 diabetes diagnosis, and three times as likely to be diagnosed with sleep apnea, the Truveta data showed.
The medications are"bringing people into primary care like never before," ResMed CEO Michael Farrell said at the company's recent shareholder meeting.
Obesity Obese Weight Loss Sleep Apnea Sleep Apnoea Sleep Disturbance Abnormal Sleep Pattern Sleep Disorder Somnipathy Sleep Transplantation Of An Organ Organ Transplantation Organ Transplant Transplantation Transplant Transplant Center Surgery Diabetes Mellitus Type 2 Diabetes Mellitus Type Ii Type 2 Diabetes Type 2 DM T2DM T2D
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Khloé Kardashian Weight Loss: Weight Loss Drugs, Fitness and DietDermatologist Dr. Angela Lamb shares what you need to know to protect your skin in the fall, including a breakdown for skin cancer screenings and a checklist to make sure your skin stays healthy even in the colder months.
Read more »
Biden proposes Medicare and Medicaid cover costly weight-loss drugs for millions of obese AmericansMillions of obese Americans would be eligible to have popular weight-loss drugs like Wegovy or Ozempic covered by Medicare or Medicaid under a new rule the Biden administration proposed Tuesday morning.
Read more »
Biden proposes Medicare and Medicaid cover costly weight-loss drugs for millions of obese AmericansMillions of obese Americans would be eligible to have popular weight-loss drugs like Wegovy or Ozempic covered by Medicare or Medicaid under a new rule the Biden administration proposed Tuesday morning.
Read more »
Biden proposes Medicare and Medicaid cover costly weight-loss drugs for millions of obese AmericansMillions of obese Americans would be eligible to have popular weight-loss drugs like Wegovy or Ozempic covered by Medicare or Medicaid under a new rule the Biden administration proposed Tuesday morning.
Read more »
Biden proposes Medicare and Medicaid cover costly weight-loss drugs for millions of obese AmericansMillions of obese Americans would be eligible to have popular weight-loss drugs like Wegovy or Ozempic covered by Medicare or Medicaid under a new rule the Biden administration proposed Tuesday morning.
Read more »
Biden proposes Medicare and Medicaid cover weight-loss drugs for obese AmericansMillions of obese Americans would be eligible to have popular weight-loss drugs like Wegovy or Ozempic covered by Medicare or Medicaid under a new rule the Biden administration proposed Tuesday morning
Read more »